FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to a HIV antibody or its antigen-binding fragment, method for its production, as well as to an immunoconjugate containing it, a composition, a set and, a chimeric antigen receptor. Nucleic acid encoding the above-mentioned antibody or its fragment, as well as a vector and a host cell containing it are also disclosed.
EFFECT: invention allows for the effective treatment of HIV infection or AIDS, as well as the detection of HIV-1 in a sample.
37 cl, 7 dwg, 5 tbl, 28 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS FOR DETECTING FOLATE RECEPTOR 1 IN PATIENT SAMPLE | 2018 |
|
RU2759410C2 |
BISPECIFIC ANTIBODIES TO CCL2 | 2020 |
|
RU2819613C1 |
BINDING MOLECULES INDUCING CELLULAR ACTIVATION | 2019 |
|
RU2770620C1 |
ANTIBODIES AGAINST CTLA4 AND THEIR USE | 2017 |
|
RU2779312C2 |
ANTIBODIES AGAINST CD40 AND THEIR USE | 2018 |
|
RU2796413C2 |
VARIANT CD3 BINDING DOMAINS AND THEIR USE IN COMBINATION THERAPY FOR TREATMENT OF DISEASES | 2019 |
|
RU2810222C2 |
LY6G6D ANTIBODIES AND METHODS OF USE | 2020 |
|
RU2818569C1 |
ANTIBODIES AGAINST TNFRSF9 AND THEIR USE | 2019 |
|
RU2812200C2 |
ANTI-C5 ANTIBODIES AND THEIR USE | 2018 |
|
RU2774716C2 |
ANTIBODIES TO PD-1 AND THEIR APPLICATION | 2017 |
|
RU2761640C2 |
Authors
Dates
2021-10-11—Published
2016-09-24—Filed